Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,382 | -24,753 | -122,611 | -73,033 | -83,447 |
| Depreciation Amortization | 19,251 | 5,507 | 8,081 | 6,850 | 5,404 |
| Income taxes - deferred | -2,126 | -25 | N/A | N/A | N/A |
| Accounts receivable | -38,837 | -13,698 | -15,848 | -10,445 | 2,251 |
| Accounts payable and accrued liabilities | 1,118 | 8,910 | 1,641 | -1,953 | 3,234 |
| Other Working Capital | -36,589 | -12,349 | 8,461 | -16,109 | 112 |
| Other Operating Activity | 116,234 | 78,314 | 111,957 | 28,554 | 11,273 |
| Operating Cash Flow | $24,669 | $41,906 | $-8,319 | $-66,136 | $-61,173 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -263,762 | -49,664 | -87,753 | 8,500 | 19,378 |
| PPE Investments | -27,408 | -19,541 | -2,986 | -5,718 | -8,930 |
| Sale Of Investment | N/A | 12,250 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -4,886 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -4,886 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-296,056 | $-56,955 | $-90,739 | $2,782 | $10,448 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 278,691 | N/A | N/A | N/A | 49,994 |
| Debt Repayment | -34,069 | N/A | -87,711 | N/A | N/A |
| Common Stock Issued | 69,816 | 24,207 | 31,966 | 570 | 2,321 |
| Other Financing Activity | 0 | 0 | 172,929 | 39,806 | 0 |
| Financing Cash Flow | $314,438 | $24,207 | $117,184 | $40,376 | $52,315 |
| Exchange Rate Effect | 387 | 191 | N/A | N/A | N/A |
| Beginning Cash Position | 51,175 | 41,826 | 23,700 | 46,678 | 45,088 |
| End Cash Position | 94,613 | 51,175 | 41,826 | 23,700 | 46,678 |
| Net Cash Flow | $43,438 | $9,349 | $18,126 | $-22,978 | $1,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,669 | 41,906 | -8,319 | -66,136 | -61,173 |
| Capital Expenditure | -27,408 | -19,541 | -2,986 | -5,718 | -8,930 |
| Free Cash Flow | -2,739 | 22,365 | -11,305 | -71,854 | -70,103 |